Who Owns Elicio Therapeutics Stock?
NASDAQ: ELTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 16.25%
- Held by insiders
- 26.98%
- Institutional holders
- 70
- Institutions 16.3%
- Insiders 27.0%
- Public and other 56.8%
Who owns Elicio Therapeutics stock?
Institutional investors own about 16.3% of Elicio Therapeutics's shares, spread across 70 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 26.98% of ELTX.
The largest institutional holders are Knoll Capital Management, LLC (4.61%), Blackrock Inc. (2.91%) and Vanguard Capital Management LLC (2.18%). Together, the top 10 institutions control 13.4% of shares outstanding. In their latest filings, 10 of the top 10 institutions increased their ELTX positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ELTX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Knoll Capital Management, LLC | 1.21M | 4.61% | +92.1% |
| Blackrock Inc. | 766.00K | 2.91% | +1413.9% |
| Vanguard Capital Management LLC | 572.15K | 2.18% | +10.3% |
| Geode Capital Management, LLC | 311.35K | 1.18% | +130.3% |
| State Street Corporation | 179.42K | 0.68% | +254.4% |
| Northern Trust Corporation | 130.16K | 0.50% | +117.9% |
| Ikarian Capital, LLC | 100.00K | 0.38% | +100.0% |
| Vanguard Portfolio Management LLC | 88.91K | 0.34% | +100.0% |
| Vanguard Fiduciary Trust Co | 88.06K | 0.34% | +27.3% |
| Alliancebernstein L.P. | 81.28K | 0.31% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ELTX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 415.40K | 1.58% |
| iShares Trust-iShares Russell 2000 ETF | 313.94K | 1.19% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 143.60K | 0.55% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 139.73K | 0.53% |
| iShares Trust-iShares Russell 2000 Growth ETF | 122.63K | 0.47% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 62.34K | 0.24% |
| iShares Trust-iShares Micro-Cap ETF | 43.43K | 0.17% |
| EQ Advisors Trust-EQ/Small Company Index Portfolio | 40.64K | 0.15% |
| EQ Advisors Trust-EQ/AB Small Cap Growth Portfolio | 40.64K | 0.15% |
| SCHWAB CAPITAL TRUST-Schwab Small-Cap Index Fund | 31.71K | 0.12% |
Frequently asked questions
Who is the largest shareholder of Elicio Therapeutics?
Knoll Capital Management, LLC is the largest institutional shareholder of ELTX, owning 4.61% of shares outstanding (1.21M shares) as of its latest 13F filing.
What percentage of Elicio Therapeutics is owned by institutions?
Institutions own about 16.3% of ELTX shares and 22.3% of the public float.
How much of Elicio Therapeutics do insiders own?
Insiders, such as officers and directors, own about 26.98% of ELTX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.